Historical record - last NADAC effective date: 8/18/2021
Product Information
SODIUM POLYSTYRENE SULF POWDER is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.5292 per GM under NDC 11534016615. Its NADAC has been published 25 times since Aug 18, 2021.
FDA first approved this application on Nov 28, 2014. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the sodium polystyrene sulfonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4.1 meq/g
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534016615
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL; RECTAL
Effective Date
8/18/2021
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA204071FDA Approved
11/28/2014
TE Code
AA
On Market Since
1/24/2017
Price Statistics
The NADAC for SODIUM POLYSTYRENE SULF POWDER has been published 25 times since Aug 18, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5292 per GM |
|---|---|
| All-time high | $0.5292 (Feb 2, 2022) |
| All-time low | $0.5292 (Aug 18, 2021) |
| Median price | $0.5292 |
| Average price | $0.5292 |
| Largest weekly change | 0.0% (Aug 25, 2021) |
| Weeks tracked | 25 |
| Tracking since | Aug 18, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
0.0%
Last surveyed Feb 2, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SODIUM POLYSTYRENE SULF POWDER?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM POLYSTYRENE SULF POWDER, manufactured by Sunrise Pharmaceutical Inc., is $0.5292 per GM (NDC 11534016615), effective Feb 2, 2022.
How has the price of SODIUM POLYSTYRENE SULF POWDER changed over time?
Over the history we have for it, the NADAC for SODIUM POLYSTYRENE SULF POWDER has held within roughly two percent of its current level. It has been tracked across 25 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for SODIUM POLYSTYRENE SULF POWDER?
Since Aug 18, 2021, the NADAC for SODIUM POLYSTYRENE SULF POWDER has ranged from a low of $0.5292 (Aug 18, 2021) to a high of $0.5292 (Feb 2, 2022), with a median of $0.5292 per GM.
Are there cheaper alternatives to SODIUM POLYSTYRENE SULF POWDER?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SODIUM POLYSTYRENE SULF POWDER, is $0.0949 per GM — about 82% below SODIUM POLYSTYRENE SULF POWDER.
Who manufactures SODIUM POLYSTYRENE SULF POWDER?
SODIUM POLYSTYRENE SULF POWDER (NDC 11534016615) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.